CU23382A3 - Metodo de producir celulas utiles para la expresion de una proteina heterologa - Google Patents

Metodo de producir celulas utiles para la expresion de una proteina heterologa

Info

Publication number
CU23382A3
CU23382A3 CU20010130A CU20010130A CU23382A3 CU 23382 A3 CU23382 A3 CU 23382A3 CU 20010130 A CU20010130 A CU 20010130A CU 20010130 A CU20010130 A CU 20010130A CU 23382 A3 CU23382 A3 CU 23382A3
Authority
CU
Cuba
Prior art keywords
cells
expression
recombinant
human
fusion
Prior art date
Application number
CU20010130A
Other languages
English (en)
Inventor
Myung-Sam Cho
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of CU23382A3 publication Critical patent/CU23382A3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

Las celulas hibridos humana fueron hechas vias fusion de celulas de rinon embrionico humano (293S) y celulas de linfoma de Burkitt modificadas (2B8). Las celulas fusion son ·tiles como celulas huespedes para la expresion recombinante de gene de mamiferos. Las ventajas del uso de estos clones hibridos de rinon humano - y celulas B, llamadas HKBs, para expresion de gen de mamifero, incluye (i) las celulas son negativas para la expresion de inmunoglobulina, (ii) las celulas crecen facilmente en plasma de medio libre de proteina (con o sin adicion de insulina recombinante) como cultura de suspension en un frasco de batir o en un fermentador (iii) las celulas son muy susceptibles para la transfeccion de ADN y (iv) las celulas segregan altos niveles de proteinas recombinantes heterologas, tales como anticuerpos monoclonales recombinantes, ICAM-1 soluble r IL-4 y r FVIII. .
CU20010130A 1998-12-10 2001-06-07 Metodo de producir celulas utiles para la expresion de una proteina heterologa CU23382A3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/209,920 US6136599A (en) 1998-12-10 1998-12-10 Human hybrid host cell for mammalian gene expression

Publications (1)

Publication Number Publication Date
CU23382A3 true CU23382A3 (es) 2009-06-25

Family

ID=22780882

Family Applications (2)

Application Number Title Priority Date Filing Date
CU20010130A CU23382A3 (es) 1998-12-10 2001-06-07 Metodo de producir celulas utiles para la expresion de una proteina heterologa
CU20020182A CU23238A1 (es) 1998-12-10 2002-08-26 CéLULAS HUéSPED PARA LA EXPRESION DE UNA PROTEINA HETEROLOGA

Family Applications After (1)

Application Number Title Priority Date Filing Date
CU20020182A CU23238A1 (es) 1998-12-10 2002-08-26 CéLULAS HUéSPED PARA LA EXPRESION DE UNA PROTEINA HETEROLOGA

Country Status (27)

Country Link
US (1) US6136599A (es)
EP (1) EP1137768B1 (es)
JP (3) JP4332300B2 (es)
KR (1) KR100627753B1 (es)
CN (1) CN1230532C (es)
AT (1) ATE306547T1 (es)
AU (1) AU757188B2 (es)
BG (1) BG65263B1 (es)
BR (1) BRPI9916095B8 (es)
CA (1) CA2353698C (es)
CU (2) CU23382A3 (es)
CZ (1) CZ302677B6 (es)
DE (1) DE69927707T2 (es)
DK (1) DK1137768T3 (es)
ES (1) ES2249929T3 (es)
HU (1) HU229775B1 (es)
ID (1) ID30448A (es)
IL (2) IL143351A0 (es)
NO (1) NO330548B1 (es)
PL (1) PL205549B1 (es)
RO (1) RO121563B1 (es)
RU (1) RU2228355C2 (es)
SI (1) SI20693B (es)
SK (1) SK287888B6 (es)
TR (1) TR200101642T2 (es)
UA (1) UA77642C2 (es)
WO (1) WO2000034462A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136599A (en) * 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression
US6358703B1 (en) * 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
US6348192B1 (en) * 1999-05-11 2002-02-19 Bayer Corporation Interleukin-2 mutein expressed from mammalian cells
US20040235715A1 (en) * 1999-11-12 2004-11-25 Bayer Corporation Method of producing glycosylated bikunin
US6569657B1 (en) * 2000-06-27 2003-05-27 Millennium Pharmaceuticals, Inc. 32140, a novel human aldehyde dehydrogenase and uses therefor
US7094587B2 (en) * 2000-06-27 2006-08-22 Millennium Pharmaceuticals, Inc. 16002 Molecules and uses therefor
US7723102B2 (en) * 2000-09-28 2010-05-25 Bayer Corporation Enhanced transfection system
MY139948A (en) * 2000-09-28 2009-11-30 Bayer Corp Enhanced transfection system
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
KR100496861B1 (ko) 2002-09-26 2005-06-22 삼성전자주식회사 하나의 핸들러에 2개 이상의 테스트 보드를 갖는 테스트장비 및 그 테스트 방법
RU2377253C2 (ru) 2002-12-02 2009-12-27 Амген Фремонт,Инк. Антитела, специфичные к фактору некроза опухолей, и их применение
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
EP3153181A1 (en) 2004-11-12 2017-04-12 Bayer HealthCare LLC Site-directed modification of fviii bdd
US8877186B2 (en) 2007-06-06 2014-11-04 Domantis Limited Polypeptides, antibody variable domains and antagonists
ES2517603T3 (es) 2008-04-07 2014-11-03 Bayer Healthcare, Llc Procedimientos de producción recombinante de glucoproteínas
KR101005967B1 (ko) * 2008-04-12 2011-01-05 (주)셀트리온 우수한 재조합 단백질을 생산하기 위한 인간 숙주 세포
US9090948B2 (en) * 2008-09-30 2015-07-28 Abbott Molecular Inc. Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
CN102612556A (zh) * 2009-06-10 2012-07-25 Bts研究国际股份有限公司 制备杂交细胞/嵌合细胞的方法及其应用
US11401514B2 (en) 2016-07-19 2022-08-02 Brandeis University Compositions and methods for identifying RNA binding polypeptide targets
CN112118869A (zh) 2018-05-16 2020-12-22 莫佛塞斯公司 靶向糖蛋白vi的抗体
TW202041535A (zh) 2019-03-14 2020-11-16 德商莫菲西斯公司 靶向C5aR的抗體
KR20230074192A (ko) 2020-09-24 2023-05-26 모르포시스 아게 인간 cd3 엡실론에 결합하는 신규의 인간 항체
CN113604425B (zh) * 2021-06-22 2022-10-18 中山康天晟合生物技术有限公司 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US6136599A (en) * 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression

Also Published As

Publication number Publication date
EP1137768B1 (en) 2005-10-12
CZ302677B6 (cs) 2011-08-31
AU757188B2 (en) 2003-02-06
TR200101642T2 (tr) 2001-11-21
SK287888B6 (sk) 2012-03-02
BR9916095A (pt) 2001-09-04
JP4332300B2 (ja) 2009-09-16
EP1137768A1 (en) 2001-10-04
NO330548B1 (no) 2011-05-16
KR20020002360A (ko) 2002-01-09
BRPI9916095B8 (pt) 2021-05-25
JP5826311B2 (ja) 2015-12-02
RU2228355C2 (ru) 2004-05-10
IL143351A0 (en) 2002-04-21
EP1137768A4 (en) 2002-09-18
DK1137768T3 (da) 2005-12-19
KR100627753B1 (ko) 2006-09-26
HUP0104681A2 (hu) 2002-04-29
CU23238A1 (es) 2007-09-26
ES2249929T3 (es) 2006-04-01
BG65263B1 (bg) 2007-10-31
UA77642C2 (en) 2007-01-15
AU1938300A (en) 2000-06-26
CA2353698A1 (en) 2000-06-15
CA2353698C (en) 2012-02-21
CN1339063A (zh) 2002-03-06
CN1230532C (zh) 2005-12-07
DE69927707T2 (de) 2006-07-13
BG105566A (en) 2002-03-29
CZ20012023A3 (cs) 2001-10-17
SK7912001A3 (en) 2002-03-05
JP2014131513A (ja) 2014-07-17
SI20693A (sl) 2002-04-30
BRPI9916095B1 (pt) 2015-10-13
JP2009148295A (ja) 2009-07-09
ATE306547T1 (de) 2005-10-15
PL205549B1 (pl) 2010-04-30
US6136599A (en) 2000-10-24
NO20012806L (no) 2001-06-07
DE69927707D1 (de) 2006-02-23
ID30448A (id) 2001-12-06
RO121563B1 (ro) 2007-11-30
HUP0104681A3 (en) 2005-10-28
IL143351A (en) 2009-12-24
HU229775B1 (en) 2014-07-28
JP5508740B2 (ja) 2014-06-04
SI20693B (sl) 2008-12-31
JP2002531125A (ja) 2002-09-24
NO20012806D0 (no) 2001-06-07
WO2000034462A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
CU23382A3 (es) Metodo de producir celulas utiles para la expresion de una proteina heterologa
CN1151263C (zh) 由细胞周期蛋白d1超量表达介导的真核细胞中所需蛋白的超量表达
RU2004107694A (ru) Способ интеграции генов в специфических сайтах в клетках млекопитающих посредством гомологичной рекомбинации и векторы для осуществления этого способа
US10329594B1 (en) Cell lines for high level production of protein-based pharmaceuticals
ES2213925T3 (es) Seleccion entre positivos y negativos en el caso de la recombinacion homologa.
CN102325881B (zh) 用于用动物细胞大量生产源自外源基因的蛋白质的表达载体及其应用
Orlik et al. Modifications of hybridoma technology which improve the yield of monoclonal antibody producing cells
US20220243192A1 (en) Hybrid yeast cell lines for high level production of recombinant protein
NZ512235A (en) Human hybrid host cell for mammalian gene expression
KR102648479B1 (ko) 단백질 기반 의약들 (protein-based pharmaceuticals) 의 고 수준 생산을 위한 세포주들 (cell lines)
Edelstein et al. Challenges and opportunities in gene editing of B cells
De Temmerman et al. Tuning the Assembly of Bispecific Antibodies by Playing on Differential Polypeptide Chain Molar Ratios
WO2023205656A2 (en) Immortalized cells for production of bioproducts, methods of producing bioproducts with an immortalized cell, and methods of making immortalized cells for production of bioproducts
CN109762820A (zh) 一种骨髓间充质干细胞特异性启动元件在干细胞中的应用
DK0671471T3 (da) Fremgangsmåde til fremstilling af fremmed protein
CN117625542A (zh) 一种用于调节nk细胞数量的msc滋养层细胞及其制备方法和应用
RU2021127370A (ru) Линия клеток, содержащая новый маркер отбора, и ее применение для продуцирования белков
CN103014055A (zh) 携带双筛选基因的真核表达载体构建及其应用

Legal Events

Date Code Title Description
FD Lapse (for not paying fees)